



The world has been astonished by the infection of a novel severe 
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), also 
known as COVID-19, since December 2019.[1] In Nigeria, the 
COVID-19 index case heralded the onset of the scourge on 
February 27, 2020.[2] Globally, the number of confirmed cases 
is astronomically rising, 18.9 million as of August 5, 2020, 
with over 0.7 million deaths.[3] Majority of the reported cases 
were adults. Children have been shown to have a low risk of 
developing symptomatic COVID-19 disease, and this may be the 
reason why they seem to be less affected hence few reportages.[4,5] 
In Nigeria, little is known of the morbidity and mortality pattern 
among persons <20 years of age who constitute about 4,000 of 
the confirmed cases as at the time of writing.[6] However, those 
with comorbidities, including sickle cell anemia (SCA), tend to 
have the severe form of the disease.[7-9]
Children with SCA, a chronic hemolytic disease, are 
predisposed to COVID-19 because it has been suggested that 
the virus causes the release of iron from hemoglobin which 
reduces its oxygen-carrying capacity and further worsens the 
anemic state.[10] Other possible mechanisms of vulnerability 
to COVID-19 include partly dysfunctional immune system, 
systemic vasculopathy, risk of thrombosis, and unavailability 
of blood donors due to social distancing measure against 
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COVID-19 infection.[11] These may be the reason the most 
common presentations among children with SCA who 
also have COVID-19 are bone pain crises and acute chest 
syndrome.[12] In general, fever and upper respiratory tract 
symptoms are the most common presenting symptoms in 
children with COVID-19 infection.[13] Meanwhile, the virus 
is transmitted through respiratory droplets while talking, 
coughing, catarrhal fluid, or sneezing from an infected person 
who may be symptomatic or not.[14] As of July 31, 2020, there 
were 284 confirmed COVID‑19 cases in SCA globally with 
one recorded child death.[12] However, there was no recorded 
case of COVID-19 among children with SCA in sub-Saharan 
Africa at that time.[12]
The pandemic has caused disruptions in the clinical 
management of common diseases, which the World Health 
Organization is trying to ameliorate.[15] The city lockdowns 
and fear of contracting the disease have made parents not to 
seek medical care for their wards in time.[16] A multicenter 
surveillance project in the United Kingdom between April 
and May 2020, and endorsed by the Royal College of 
Paediatrics and Child Health, found out that 3% of delayed 
presentations to the emergency room were due to parental 
decisions.[17] Overzealous COVID‑19 preventive measures 
among health workers have also led to delayed diagnosis 
of life-threatening emergencies.[18] This also may not be 
unconnected with the adverse psychological effects of 
coming in contact with a case of suspected COVID-19.[19] To 
mitigate these challenges, health institutions and personnel 
are now utilizing telemedicine to reach out to their 
patients.[20]
Telemedicine is defined as the use of electronic information 
and communication technologies to provide and support 
health care when distance separates the participants.[21] 
Its forms of application includes live video conferencing, 
store-and-forward video conferencing, remote patient 
monitoring, and mobile health.[22] Mobile health can easily 
be practiced in low-middle income countries unlike the other 
forms that require a constant power supply, internet service, 
availability and affordability of SMART (Self-Monitoring, 
Analysis and Reporting Technology) phones and gadgets. 
Mobile health entails the use of mobile devices like handset 
phones which are available even in rural areas. Information can 
be exchanged via phone calls and texts between the physician 
and the patient or patient relative.
From the foregoing, the clinical experience on the use of 
mobile health telemedicine at the early stages of the COVID-19 
pandemic in a hospital unit of a resource-poor tertiary center 
was assessed.
Methods
The study took place in a tertiary hospital in the Niger-Delta 
region of Nigeria which serves as a referral center to general 
and private hospitals and to neighboring states of the region. 
In the pre-COVID era, its peadiatric hemato-oncology clinic 
sees 7–15 children with SCA weekly, while the peadiatric 
emergency room admits 2–3 children with SCA weekly.
Virtual meeting of the four consultants in the peadiatric 
hemato-oncology unit was held when the national lockdown 
to reduce COVID-19 transmission started in late March 
2020. In order to prevent COVID-19 infection, it was agreed 
that communication be created between the doctors and the 
patients’ caregivers through phone calls and text messaging.
Names and phone numbers of all parents of the patients with 
SCA were obtained from the e-registry of the peadiatric 
hemato-oncology unit. Text messages with advice to call the 
stated phone lines of any of the four attending peadiatrician 
before coming to the hospital were sent to 271 parents on 
March 28, 2020. The Message also had information on what 
to do when their children are sick. Similar messages were 
also sent to the Sickle Cell Support Network, an organization 
that focuses on advocacy and good health of persons with 
SCA. This cross-sectional project was approved by the Health 
Research Ethical Committee of the hospital.
Information on the date of the phone call from parents, 
biodata (name, age and sex) of child, complaints, other necessary 
clinical interviews, and intervention prescribed were kept by 
each of the doctors after obtaining informed verbal consent to 
do so in the first encounter. By the second encounter, on day 7, 
caregivers were asked to give feedback on whether they prefer 
physical meeting or mobile health telemedicine for future 
encounters and the outcome of the child’s health. Preference for 
mobile health telemedicine was taken as favorable because of 
the SARS-CoV-2 pandemic.
Those with difficulty in breathing, worsening paleness and/or 
yellowness of eyes, and severe bone and/or abdominal pain 
not improving with the prescribed intervention were asked to 
go to the emergency room, and their details were immediately 
forwarded to the emergency physician on duty to reduce delay 
in management. Those with COVID-like symptoms were to 
be isolated and undergo a test for the virus.
Statistical analysis
Information extracted from each physician’s book was collated 
and analyzed with SPSS version 23.0. Categorical variables 
were presented as frequencies and percentages. Line graphs 
and histograms were derived from the frequency of the 
encounters. Data were skewed. Comparisons of responses 
and feedbacks across the months were done with Kruskal–
Wallis H-test. Post hoc analysis was further done for the 
responses. Mann–Whitney U‑test was used in analyzing 
symptoms in both encounters, while Fisher’s exact test was 
used in comparing the choice of the type of future encounters. 
Statistical significance was set at P < 0.05 at 95% confidence 
interval.
results
As of August 5, 2020, the hospital has had no documented or 
recorded case of confirmed COVID‑19 in any child with SCA, 
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and as the lockdowns were lifted, the number of children with 
SCA seen per week in the clinic dwindled to 5.
Of the 271 text messages that were sent out, there were 158 
individual responses with 115 calls and 43 text messages from 
the parents/guardians by the end of July 2020. The difference 
in the responses was statistically significant across April and 
July [Tables 1a and b].
The following symptoms were recorded: respiratory (cough, 
catarrh, and difficulty in breathing) (85 [40%]), bone 
pain and abdominal pain (57 [27%]), fever (34 [16%]), 
worsening paleness (21 [10%]), worsening yellowness of 
the eyes (12 [6%]), and abdominal swelling (2 [1%]). The 
most frequently observed symptom in each month was 
respiratory [Figure 1].
The prescribed interventions for these symptoms 
were verbal drug prescriptions (49 [31%]) and routine 
counseling (93 [59%]), while 16 (10%) respondents were 
asked to visit the emergency room where their children were 
admitted. These interventions peaked in June [Figure 2]. No 
death was recorded during the period and outcome by day 
7, following the intervention, showed few symptoms. The 
difference between each symptom during both encounters 
was statistically significant (P < 0.001), except abdominal 
swelling [Table 2].
In addition to the outcome, 96 (60.8%) respondents elected to 
continue mobile health telemedicine for future interactions. 
Parents (10%) of the admitted children preferred physical 
meeting, while 34 (21.5%) respondents were either undecided 
or wanted both forms of interactions. The differences between 
those that wanted a physical meeting and mobile health 
across the months were statistically significant [Table 3]. 
However, the course of communications over the months 
showed an upward trend [Figure 3]. Calls increased as follows: 
19 (16.5%) in April, 29 (25.2%) in May, 28 (24.4%) in June, 
and 39 (33.9%) in July, while texts increased as follows: 
10 (23.3%) in April, 9 (20.9%) in May, 11 (25.6%) in June, 
and 13 (30.2%) in July.
dIscussIon
This study has shown that there was a gradual increase 
in the usage of phones to communicate with physicians. 
Respiratory symptoms, bone pain and abdominal pain were 
the most common complaints. The most frequently prescribed 
interventions were drugs and counselling which led to a marked 
reduction of symptoms 7 days later. Majority of the respondents 
opted to continue using mobile health telemedicine.
All the parents/guardians did not participate in the survey. The 
response rate was 58.3%. The possible reasons for non-response 
from 41.7% of the parents may be that their children were 
healthy during the study period; the parents did not have airtime 
to call the physicians or that the initial message was not received.
However, the response steadily increased over the months, 
with a significant difference between responses in April and 
Table 1a: Response across the months (N=271)
Month 
in 2020





Calls 19 (7.01) 563.50 χ2=7.97 0.047*
Texts 10 (3.69)
Total 29 (10.70) 242 (89.3)
May
Calls 29 (10.70) 545.50
Texts 9 (3.32)
Total 38 (14.02) 233 (86.0)
June
Calls 28 (10.33) 543.50
Texts 11 (4.06)
Total 39 (14.39) 232 (85.6)
July
Calls 39 (14.39) 517.50
Texts 13 (4.80)




Total 158 (58.30) 113 (41.70)
*Statistically significant; H-test: Kruskal-Wallis H-test; χ2 = Chi square.
Table 1b: Pairwise comparison of months








Nigerian Journal of Medicine ¦ Volume 30 ¦ Issue 1 ¦ January-February 202130
Figure 1: Monthly occurrence of symptoms among children with 
sickle cell anemia during the COVID‑19 pandemic in Nigeria. VOC: 
vaso‑occlusive painful crises
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July. This may imply that the parents are in harmony with this 
current step of discussing their children via phone with their 
physicians in other to limit COVID-19 spread. Davis et al[23] 
have demonstrated that 82% of their patients were likely to 
prefer telemedicine over physical consultation during flu 
seasons.
Flu is common during peak rainy season (April through 
August) in Nigeria, and this may be the reason majority of the 
recorded symptoms were respiratory which resolved either at 
home or in the emergency room. However, in this COVID-19 
pandemic, one should be careful of these symptoms despite 
no recording of confirmed COVID‑19 which may, in addition, 
be due to low testing capacity in our locality.
A week after each initial encounter, majority of the symptoms 
significantly resolved across the months. This may not 
be unconnected with the advice to buy over-the-counter 
medications and counselling which were the main intervention 
prescribed. Continuation of routine medications (hydroxyurea, 
folic acid, penicillin V and proguanil) and liberal fluid 
intake were reiterated for those with what seemed like 
mild-to-moderate vaso-occlusive painful crises.
In addition, most respondents (60.8%) wanted to continue the 
use of mobile health telemedicine in future interactions. The 
difference among respondents who wanted a physical meeting 
and mobile health significantly increased from April through 
July. This preference for mobile health telemedicine may be 
due to the national lockdown and fear of contracting the deadly 
Table 2: Symptoms during initial encounter and second (outcome) encounter (n=158)
Variable First encounter (symptom) Second encounter (symptom) U p-value
Frequency, n (%) Mean rank Frequency, n (%) Mean rank
Cough 43 (27.2) 29.00 14 (8.9) 58.00 301.00 <0.001*
Catarrh 34 (21.5) 21.50 8 (5.1) 47.50 136.00 <0.001*
Fever 34 (21.5) 17.50 0 (0.0) 51.50 0.00 <0.001*
Difficulty in breathing 8 (5.1) 4.50 0 (0.0) 12.50 0.00 <0.001*
Bone pain 43 (27.2) 23.50 3 (1.9) 63.50 64.50 <0.001*
Whitening palms and soles 21 (13.2) 13.50 5 (3.2) 29.50 52.50 <0.001*
Worsening yellow of eyes 12 (7.6) 6.50 0 (0.0) 18.50 0.00 <0.001*
Abdominal pain 14 (8.9) 8.50 2 (1.3) 20.50 14.00 <0.001*
Abdominal swelling 2 (1.3) 1.50 0 (0.0) 3.50 0.00 <0.083
*Statistically significant. U=Mann-Whitney U-test
Table 3: Feedback on further mode of interaction from parents across the months
Month in year 2020 Feedback on further mode of interaction Test statistic 
(FET)
p-value
Physical meeting, n (%) Mobile health (handset phone use), n 
(%)
April (n=29) 6 (20.7) 16 (55.2) 6.147 0.020*
May (n=38) 7 (18.4) 23 (60.5) 5.596 0.029*
June (n=39) 7 (17.9) 24 (61.5) 5.332 0.031*
July (n=52) 8 (15.4) 33 (63.5) 5.444 0.021*
*Statistically significant. FET: Fisher’s exact test
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Figure 2: Verbally administered interventions on children with sickle cell 
anemia during the COVID‑19 pandemic in Nigeria
Figure 3: Trend of communication with parents of children with sickle 
cell anemia over the first 4 months of COVID‑19 pandemic in Nigeria
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virus, and it may have led to the reduced number of patients 
seen in clinic after the lockdown. Therefore, mobile health 
telemedicine is favourable.
The lack of a confirmed case of COVID‑19 among children 
with SCA in the center may be due to the enforcement of 
preventive measures and continuous education through the 
media by the government. Another possible reason for low 
COVID-19 prevalence among children with SCA may be the 
protective effect of normally high levels of interleukins 1, 6, 
and 17; tumor necrotic factor-alpha; monocyte chemoattractant 
protein‑1; and macrophage inflammatory protein 1‑α.[24] These 
cytokines and chemokines are usually increased in COVID-19 
infection and are responsible for the inflammation (cytokine 
storm) seen in the severe form of the disease.[25] Since children 
with SCA are used to these cytokines, they may not be 
symptomatic or present with the severe form of COVID-19. 
Nevertheless, parents of these children should continually be 
advised via text messaging on the use of face masks because 
the case fatality rate in Nigeria rose to 2.0% as of August 5, 
2020.[6,26]
conclusIon
The use of handset phones for telemedicine mobile health 
is a valuable tool that helps in reducing morbidity among 
children with SCA, especially during this COVID-19 era in a 
low-middle-income country, even as the lockdowns are being 
gradually relaxed. Most of the caregivers who are indigent may 
not afford smartphones for video conferencing, and internet 
services may either be absent or at best, poor in the rural areas. 
Mobile health telemedicine aids in bridging the gap between 
doctors and their patients in other to maintain care and keep 
COVID-19-related childhood SCA mortality minimum. The use 
of mobile health in a resource-poor clinical setting is another way 
of protecting doctors as there are few of them in Nigeria (about 
4 medical doctors per 10,000 population as of 2018).[27,28] 
Elsewhere, patients have embraced telemedicine as a safe way of 
connecting with their physicians.[23,29] Audio-visual conferencing 
is obviously better than audio alone. Efforts should be made by 
relevant authorities to institute video conferencing by creating 
free communication links between rural and specialist hospitals.
Limitations of the study
1. After the first and day 7 encounters, subsequent care 
provider-driven encounters were not done as a follow-up 
to the initial interactions due to lack of funding. This 
would have given a clearer picture of the trend of the 
child’s illness and outcomes, especially among those that 
did not call back
2. Audio-visual communication would have been a better 
form of telemedicine in these interactions because the 
physician may be able to discern visually what the parent 
is finding it difficult to explain. However, the resources 
are unavailable.
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